Atrial Fibrillation (AF) is the most common arrhythmia (irregular heart rhythm disorder), which is having a huge and increasing burden on patients…

Jennifer Turgiss leads the behaviour science and analytics teams at Johnson & Johnson (J&J), applying her expertise in behavioural and social science to develop digital health behaviour change interventions. We spoke to Jennifer at this year’s eyeforpharma, Barcelona on her long-standing career in the Health and Wellness industry and scaling bespoke patient behaviour change programmes.

KEEPING skin moisturised and in good condition could decrease the risk of several chronic conditions such as heart disease, Alzheimer’s, and diabetes..

YEAST species responsible for protection against fungi on the skin is also pivotal in the development of atopic dermatitis symptoms..

Prof Salles provided an update on the ongoing first-line follicular lymphoma (FL) studies, demonstrating how analysis of the GALLIUM study data regarding…

Cesar Sanz Rodriguez is Associate Vice President, Medical Affairs Lead Mid-Europe (MER), Eastern Europe, Middle East & Africa (EEMEA) Regions. He spoke to us about his progression into medical affairs from a clinical background, the changing role of medical affairs in the pharma industry, and the exciting advances currently taking place in cancer treatment.

RESEARCH into early-onset colorectal cancer (CRC) has found unique subgroups among younger patients and has outlined risk factors and prevalence of…